4572
Carna Biosciences,Inc.
カルナバイオサイエンス
- Industry
- Pharmaceutical
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Dec 2021
2,017,529
Dec 2022
1,386,748
Dec 2023
1,625,889
Dec 2024
636,235
Dec 2025
579,057
Operating profit(thousand JPY)
Dec 2021
-531,135
Dec 2022
-1,269,888
Dec 2023
-1,116,978
Dec 2024
-2,076,104
Dec 2025
-2,074,972
Operating profit margin(%)
Dec 2021
-26.33
Dec 2022
-91.57
Dec 2023
-68.7
Dec 2024
-326.31
Dec 2025
-358.34
Profit before tax(thousand JPY)
Dec 2021
-532,499
Dec 2022
-1,323,399
Dec 2023
-1,130,846
Dec 2024
-2,173,976
Dec 2025
-2,169,619
Profit(thousand JPY)
Dec 2021
-534,474
Dec 2022
-1,349,539
Dec 2023
-1,152,895
Dec 2024
-2,178,576
Dec 2025
-2,171,470
Total assets(thousand JPY)
Dec 2021
5,432,560
Dec 2022
4,266,453
Dec 2023
4,349,891
Dec 2024
2,772,115
Dec 2025
1,229,648
Cash and cash equivalents(thousand JPY)
Dec 2021
3,817,834
Dec 2022
3,379,048
Dec 2023
2,889,101
Dec 2024
2,108,484
Dec 2025
516,789
Cash flows from operating activities(thousand JPY)
Dec 2021
-1,536,612
Dec 2022
-708,390
Dec 2023
-1,677,464
Dec 2024
-1,374,806
Dec 2025
-2,159,363
Cash flows from investing activities(thousand JPY)
Dec 2021
-41,677
Dec 2022
-125,696
Dec 2023
-11,376
Dec 2024
-13,060
Dec 2025
-25,009
Cash flows from financing activities(thousand JPY)
Dec 2021
1,064,987
Dec 2022
367,006
Dec 2023
1,182,027
Dec 2024
567,441
Dec 2025
604,711
Return on equity(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Equity ratio(%)
Dec 2021
79.3
Dec 2022
85
Dec 2023
89.1
Dec 2024
89.3
Dec 2025
25.1
Earnings per share(JPY per share)
Dec 2021
-42.1
Dec 2022
-99.1
Dec 2023
-68.62
Dec 2024
-121.64
Dec 2025
-113.62
Net assets per share(JPY per share)
Dec 2021
323.54
Dec 2022
255.04
Dec 2023
226.16
Dec 2024
129.62
Dec 2025
16.16
Dividend per share(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Payout ratio(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.